Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single cell analysis

View ORCID ProfileKai Huang, Catherine Wang, Christen Vagts, Vanitha Raguveer, View ORCID ProfilePatricia W. Finn, David L. Perkins
doi: https://doi.org/10.1101/2021.03.26.21254445
Kai Huang
1Division of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago IL, 60612 United States
2Department of Bioengineering, University of Illinois at Chicago, Chicago IL, 60612 United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kai Huang
Catherine Wang
3College of Medicine, University of Illinois at Chicago, Chicago IL, 60612 United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christen Vagts
1Division of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago IL, 60612 United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanitha Raguveer
3College of Medicine, University of Illinois at Chicago, Chicago IL, 60612 United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia W. Finn
1Division of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago IL, 60612 United States
2Department of Bioengineering, University of Illinois at Chicago, Chicago IL, 60612 United States
4Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago IL, 60612 United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patricia W. Finn
  • For correspondence: pwfinn@uic.edu
David L. Perkins
2Department of Bioengineering, University of Illinois at Chicago, Chicago IL, 60612 United States
5Division of Nephrology, Department of Medicine, University of Illinois at Chicago, Chicago IL, 60612 United States
6Department of Surgery, University of Illinois at Chicago, Chicago IL, 60612 United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Hyperactive and damaging inflammation is a hallmark of severe rather than mild COVID-19 syndrome. To uncover key inflammatory differentiators between severe and mild COVID-19 disease, we applied an unbiased single-cell transcriptomic analysis. We integrated a bronchoalveolar lavage (BAL) dataset with a peripheral blood mononuclear cell dataset (PBMC) and analyzed the combined cell population, focusing on genes associated with disease severity. Distinct cell populations were detected in both BAL and PBMC where the immunomodulatory long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 were highly differentially expressed between mild and severe patients. The detection of other severity associated genes involved in cellular stress response and apoptosis regulation suggests that the pro-inflammatory functions of these lncRNAs may foster cell stress and damage. The lncRNAs NEAT1 andMALAT1 are potential components of immune dysregulation in COVID-19 that may provide targets for severity related diagnostic measures or therapy.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by F30HL151182 (KH), T32HL144909 (CV), R01HL138628, and U01AI132898. No other payment or services were received from a third party for any aspect of this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This work utilized publicly available deidentified data.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • This revision includes new sections highlighting validation data that further reinforces the conclusions of the original submission. Additional supplemental data is provided.

Data Availability

Data for BAL and PBMCs were downloaded from the NCBI Gene Expression Omnibus (accession number GSE145926) and the COVID-19 Cell Atlas (https:/www.covid19cellatlas.org/#wilk20), respectively. Data for validation was donwloaded from the following sources: nasopharyngeal validation - EGAS00001004481 (data downloaded from https://doi.org/10.6084/m9.figshare.12436517), and PBMC validation - EGAS00001004571(downloaded from https://beta.fastgenomics.org/datasets/detail-dataset-952687f71ef34322a850553c4a24e82e#Files)

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE145926

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted July 31, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single cell analysis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single cell analysis
Kai Huang, Catherine Wang, Christen Vagts, Vanitha Raguveer, Patricia W. Finn, David L. Perkins
medRxiv 2021.03.26.21254445; doi: https://doi.org/10.1101/2021.03.26.21254445
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single cell analysis
Kai Huang, Catherine Wang, Christen Vagts, Vanitha Raguveer, Patricia W. Finn, David L. Perkins
medRxiv 2021.03.26.21254445; doi: https://doi.org/10.1101/2021.03.26.21254445

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8783)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1861)
  • Geriatric Medicine (178)
  • Health Economics (388)
  • Health Informatics (1291)
  • Health Policy (644)
  • Health Systems and Quality Improvement (491)
  • Hematology (207)
  • HIV/AIDS (394)
  • Infectious Diseases (except HIV/AIDS) (10557)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1754)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (342)
  • Occupational and Environmental Health (461)
  • Oncology (964)
  • Ophthalmology (282)
  • Orthopedics (107)
  • Otolaryngology (176)
  • Pain Medicine (117)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (264)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1843)
  • Public and Global Health (3983)
  • Radiology and Imaging (654)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)